Two Simple Methods for Optimizing the Production of "Difficult-to-Express" GnRH-DFF40 Chimeric Protein

Mahdi Barazesh ¹ , Zohreh Mostafavipour ^2,3 , Soudabeh Kavousipour ¹, Shiva Mohammadi ¹ , Pooneh Mokarram ² *

Cited by CrossRef: 3

1- Hussain H, McKenzie E, Robinson A, Gingles N, Marston F, Warwicker J, Dickson A. Predictive approaches to guide the expression of recombinant vaccine targets in Escherichia coli: a case study presentation utilising Absynth Biologics Ltd. proprietary Clostridium difficile vaccine antigens. Appl Microbiol Biotechnol. 2021;105(13):5657 [Crossref]

2- Movahedpour A, Ahmadi K, Taheri-Anganeh M, Amiri A, Ahmadi N, Khatami S, Zafaranchi z.m S, Soltani Fard E, Moazamfard M, Ghasemi H, Nezafat N. Designing a Humanized Immunotoxin Based on HER2 Specific scFv and DFF40 Toxin Against Breast Cancer: An In-Silico Study. Int J Pept Res Ther. 2022;28(5) [Crossref]

3- Fink M, Schimek C, Cserjan‐Puschmann M, Reinisch D, Brocard C, Hahn R, Striedner G. Integrated process development: The key to improve Fab production in E. coli. Biotechnology Journal. 2021;16(6) [Crossref]